Chemotherapy drugs can cause severe side effects and complications when administered through external intravenous lines. To reduce the risk of skin necrosis and limit drug side effects, a subcutaneous injection chamber technique is utilized for cancer patients at risk of extravasation. This device is implanted under the skin of the chest wall to support intravenous drug and nutrition infusion, providing a more secure and convenient method of drug delivery.
Extravasation is a common complication when injecting drugs into peripheral veins, causing irritation, ulcers, and skin necrosis. Older patients, those with weak vessel walls, obesity, edema, or skin lesions are more susceptible to this condition. The subcutaneous injection chamber provides a targeted delivery of chemotherapy drugs without the risk of complications associated with intravenous administration, resulting in reduced side effects and improved outcomes. Patients who undergo the placement of a subcutaneous injection chamber have experienced improved convenience and effectiveness in their cancer treatment.
The procedure for implanting a subcutaneous injection chamber involves placing the device under the skin of the chest wall, with a catheter inserted into a central vein to facilitate drug delivery. The incision is sutured and bandaged to prevent infection, and patients can resume their daily activities once the device is in place. Regular monitoring and care are required to ensure the longevity and effectiveness of the subcutaneous injection chamber, which can last up to 1-2 years before replacement may be necessary.
By incorporating innovative technologies and methods into cancer care, healthcare providers can improve patient outcomes and enhance the quality of life for individuals undergoing challenging cancer treatments. The use of subcutaneous injection chambers offers a safe and efficient way to administer chemotherapy drugs to patients at risk of extravasation, providing a more comfortable and effective treatment experience.
